US patent for BCR Diagnostic's amplification technology:
This article was originally published in Clinica
Executive Summary
Rhode Island-based BCR Diagnostics (US) has been granted a US patent for its Bacterial Chain Reaction amplification and visualisation technology. The BCR system amplifies and visualises signals from biomolecular probes such as antibodies, binding proteins and nucleic acid probes by using micro-organisms as nanodevices. The company believes the BCR technology could be useful in, among other things, cancer cell detection in blood and bone marrow, in situ PCR, ELISA and blotting techniques. President Boris Rotman says his company plans to expand the applications in other diagnostic tests through licensing out the technology.